LNDZF (Evome Medical Technologies) Beta : 0.39 (As of Dec. 11, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-11), Evome Medical Technologies's Beta is 0.39.

Evome Medical Technologies Beta Historical Data

The historical data trend for Evome Medical Technologies's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Beta Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Beta

Get a 7-Day Free Trial

2.12

1.26

1.45

1.83

1.16

Evome Medical Technologies Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beta	Get a 7-Day Free Trial															0.97	1.16	1.12	0.12	0.12

Competitive Comparison of Evome Medical Technologies's Beta

For the Medical Devices subindustry, Evome Medical Technologies's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evome Medical Technologies's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's Beta distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's Beta falls into.

Evome Medical Technologies Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Evome Medical Technologies (OTCPK:LNDZF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Evome Medical Technologies Beta Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.